In his conversation with Andrew Schulz, he admitted to "basically playing doctor," telling injured buddies to try BPC-157 "with no research" behind his recommendation
Bottom Line Microdosing semaglutide can be a legitimate tool for the right person: someone with moderate weight to lose, a decent metabolic baseline, and access to a legitimate prescription
Collins J, Jones L, Snyder M, Sicard E, Griffin P, Webster L, et al
HSA (Health Savings Account): Funds roll over annually, making them a great option for long-term health expenses
GI tolerance Some patients experience persistent nausea or constipation on semaglutide
When patients see a clear path to manageable monthly payments, they are more likely to proceed with medically recommended treatment